Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Branded Generics market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Branded Generics market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Branded Generics market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Branded Generics products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Branded Generics products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Branded Generics market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Branded Generics development has been the leading industry trend of Branded Generics market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Branded Generics Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Value Added Branded Generics, Trade (Brand) Named Generics, Other |
| By Application Outlook |
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Abbott Laboratories, Apotex, AstraZeneca, Dr.Reddy�s Laboratories, GlaxoSmithKline, Hospira, Lupin, Mylan N.V, Novartis AG, Par Pharmaceutical, Sandoz, Sanofi, Teva Pharmaceutical, Valeant, ZydusCadila, Others |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Abbott Laboratories
- Apotex
- AstraZeneca
- Dr.Reddy�s Laboratories
- GlaxoSmithKline
- Hospira
- Lupin
- Mylan N.V
- Novartis AG
- Par Pharmaceutical
- Sandoz
- Sanofi
- Teva Pharmaceutical
- Valeant
- ZydusCadila
- Others
Branded Generics Market, By Type
- Value Added Branded Generics
- Trade (Brand) Named Generics
- Other
Branded Generics Market, By Application
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
- Others
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Branded Generics Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Branded Generics Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Value Added Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Trade (Brand) Named Generics Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Branded Generics Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Branded Generics Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Branded Generics Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Branded Generics Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Branded Generics Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Branded Generics Market Assessment by Type
8.1 Asia Pacific Branded Generics Market Assessment by Application (Consumption and Market Share)
8.2 North America Branded Generics Market Assessment by Application (Consumption and Market Share)
8.3 Europe Branded Generics Market Assessment by Application (Consumption and Market Share)
8.4 South America Branded Generics Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Branded Generics Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Profiles
9.1.2 Abbott Laboratories Product Portfolio
9.1.3 Abbott Laboratories Branded Generics Business Performance
9.1.4 Abbott Laboratories Branded Generics Business Development and Market Status
9.2 Apotex
9.2.1 Apotex Profiles
9.2.2 Apotex Product Portfolio
9.2.3 Apotex Branded Generics Business Performance
9.2.4 Apotex Branded Generics Business Development and Market Status
9.3 AstraZeneca
9.3.1 AstraZeneca Profiles
9.3.2 AstraZeneca Product Portfolio
9.3.3 AstraZeneca Branded Generics Business Performance
9.3.4 AstraZeneca Branded Generics Business Development and Market Status
9.4 Dr.Reddy’s Laboratories
9.4.1 Dr.Reddy’s Laboratories Profiles
9.4.2 Dr.Reddy’s Laboratories Product Portfolio
9.4.3 Dr.Reddy’s Laboratories Branded Generics Business Performance
9.4.4 Dr.Reddy’s Laboratories Branded Generics Business Development and Market Status
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Profiles
9.5.2 GlaxoSmithKline Product Portfolio
9.5.3 GlaxoSmithKline Branded Generics Business Performance
9.5.4 GlaxoSmithKline Branded Generics Business Development and Market Status
9.6 Hospira
9.6.1 Hospira Profiles
9.6.2 Hospira Product Portfolio
9.6.3 Hospira Branded Generics Business Performance
9.6.4 Hospira Branded Generics Business Development and Market Status
9.7 Lupin
9.7.1 Lupin Profiles
9.7.2 Lupin Product Portfolio
9.7.3 Lupin Branded Generics Business Performance
9.7.4 Lupin Branded Generics Business Development and Market Status
9.8 Mylan N.V
9.8.1 Mylan N.V Profiles
9.8.2 Mylan N.V Product Portfolio
9.8.3 Mylan N.V Branded Generics Business Performance
9.8.4 Mylan N.V Branded Generics Business Development and Market Status
9.9 Novartis AG
9.9.1 Novartis AG Profiles
9.9.2 Novartis AG Product Portfolio
9.9.3 Novartis AG Branded Generics Business Performance
9.9.4 Novartis AG Branded Generics Business Development and Market Status
9.10 Par Pharmaceutical
9.10.1 Par Pharmaceutical Profiles
9.10.2 Par Pharmaceutical Product Portfolio
9.10.3 Par Pharmaceutical Branded Generics Business Performance
9.10.4 Par Pharmaceutical Branded Generics Business Development and Market Status
9.11 Sandoz
9.12 Sanofi
9.13 Teva Pharmaceutical
9.14 Valeant
9.15 ZydusCadila
9.16 Others
10 World Branded Generics Market Assessment by Players
10.1 Global Branded Generics Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Branded Generics Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Branded Generics Price (USD/Unit) of Players 2014-2020
10.4 Global Branded Generics Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Branded Generics Sales Assessment of Players 2014-2020
11.1.2 North America Branded Generics Revenue Assessment of Players 2014-2020
11.1.3 North America Branded Generics Price Assessment of Players 2014-2020
11.1.4 North America Branded Generics Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Branded Generics Sales Assessment of Players 2014-2020
11.2.2 Europe Branded Generics Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Branded Generics Price Assessment of Players 2014-2020
11.2.4 Europe Branded Generics Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Branded Generics Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Branded Generics Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Branded Generics Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Branded Generics Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Branded Generics Sales Assessment of Players 2014-2020
11.4.2 South America Branded Generics Revenue Assessment of Players 2014-2020
11.4.3 South America Branded Generics Price Assessment of Players 2014-2020
11.4.4 South America Branded Generics Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Branded Generics Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Branded Generics Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Branded Generics Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Branded Generics Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Branded Generics Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Branded Generics Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Branded Generics Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Branded Generics Sales by Countries/Regions 2014-2020
12.2.2 North America Branded Generics Revenue by Countries/Regions 2014-2020
12.2.3 North America Branded Generics Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Branded Generics Sales by Countries/Regions 2014-2020
12.3.2 Europe Branded Generics Revenue by Countries/Regions 2014-2020
12.3.3 Europe Branded Generics Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Branded Generics Sales by Countries/Regions 2014-2020
12.4.2 South America Branded Generics Revenue by Countries/Regions 2014-2020
12.4.3 South America Branded Generics Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Branded Generics Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Branded Generics Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Branded Generics Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Branded Generics Sales & Revenue Forecast 2021-2026
14.1 World Branded Generics Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Branded GenericsSales and Market Share by Regions
14.1.2 World Branded GenericsRevenue and Market Share by Regions
15 Asia Branded Generics Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Value Added Branded Generics
15.1.2 Trade (Brand) Named Generics
15.2 Consumption Forecast by Application, 2021-2026
16 North America Branded Generics Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Value Added Branded Generics
16.1.2 Trade (Brand) Named Generics
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Branded Generics Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Value Added Branded Generics
17.1.2 Trade (Brand) Named Generics
17.2 Consumption Forecast by Application, 2021-2026
18 South America Branded Generics Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Value Added Branded Generics
18.1.2 Trade (Brand) Named Generics
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Branded Generics Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Value Added Branded Generics
19.1.2 Trade (Brand) Named Generics
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Branded Generics Price (USD/Unit) Trend 2021-2026
20.2 Global Branded Generics Gross Profit Trend 2021-2026
21 Conclusion
